CALR and acquired polycythemia vera: However, studies have found TP53 mutations in 70% of patients with PV-related MF [99] and approximately 8% of PV patients [158] with a very low allele burden [100], and TP53-mutated subclones within JAK2 or CALR-mutated populations [158].